litlas
ログインアカウント作成

Thomas R. Fleming

1978–2024 年に発表

別表記
Thomas R Fleming
101
論文数
43,572
被引用数
79
h 指数
98
i10 指数

被引用数

Thomas R. Fleming の年別被引用数1966 年: 被引用 1 件1979 年: 被引用 1 件1981 年: 被引用 7 件1982 年: 被引用 10 件1983 年: 被引用 9 件1984 年: 被引用 27 件1985 年: 被引用 13 件1986 年: 被引用 22 件1987 年: 被引用 25 件1988 年: 被引用 30 件1989 年: 被引用 40 件1990 年: 被引用 52 件1991 年: 被引用 64 件1992 年: 被引用 68 件1993 年: 被引用 67 件1994 年: 被引用 109 件1995 年: 被引用 84 件1996 年: 被引用 81 件1997 年: 被引用 114 件1998 年: 被引用 148 件1999 年: 被引用 161 件2000 年: 被引用 182 件2001 年: 被引用 204 件2002 年: 被引用 202 件2003 年: 被引用 191 件2004 年: 被引用 215 件2005 年: 被引用 270 件2006 年: 被引用 239 件2007 年: 被引用 278 件2008 年: 被引用 307 件2009 年: 被引用 267 件2010 年: 被引用 282 件2011 年: 被引用 262 件2012 年: 被引用 332 件2013 年: 被引用 336 件2014 年: 被引用 340 件2015 年: 被引用 274 件2016 年: 被引用 251 件2017 年: 被引用 225 件2018 年: 被引用 247 件2019 年: 被引用 811 件2020 年: 被引用 704 件2021 年: 被引用 681 件2022 年: 被引用 600 件2023 年: 被引用 370 件2024 年: 被引用 491 件2025 年: 被引用 222 件2026 年: 被引用 19 件1967〜1978 年は被引用が無いため表示していません1980 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,894 件、この内訳の 30.3%イギリス: 引用元論文 1,352 件、この内訳の 8.4%カナダ: 引用元論文 769 件、この内訳の 4.8%ドイツ: 引用元論文 718 件、この内訳の 4.4%フランス: 引用元論文 648 件、この内訳の 4%イタリア: 引用元論文 606 件、この内訳の 3.8%中国: 引用元論文 527 件、この内訳の 3.3%オランダ: 引用元論文 492 件、この内訳の 3%オーストラリア: 引用元論文 463 件、この内訳の 2.9%スイス: 引用元論文 398 件、この内訳の 2.5%南アフリカ: 引用元論文 379 件、この内訳の 2.3%スペイン: 引用元論文 297 件、この内訳の 1.8%
0%30.3%その他 28.5%

機関

分野

  • Medicine72.4%
  • Mathematics7.2%
  • Biochemistry, Genetics and Molecular Biology5.3%
  • Immunology and Microbiology3.7%
  • Nursing2.1%
  • Computer Science1.5%
  • その他7.8%

トピック

  • HIV/AIDS Research and Interventions6.4%
  • HIV Research and Treatment3.1%
  • HIV, Drug Use, Sexual Risk2.3%
  • HIV/AIDS drug development and treatment2.3%
  • Pulmonary Hypertension Research and Treatments2.3%
  • Adolescent Sexual and Reproductive Health1.8%
  • その他81.8%

共著者

全論文

検索で開く
  1. Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

    著者: Douglas L. Mann, John J.V. McMurray, Milton Packer, Karl Swedberg, Jeffrey Borer, Wilson S. Colucci, Jacques Djian, Helmut Drexler, Arthur M. Feldman, Lars Køber, Henry Krum, Peter Liu, Markku S. Nieminen, Luigi Tavazzi, Dirk Jan van Veldhuisen, Anders Waldenström, Marshelle Warren, Arne Westheim, Faı̈ez Zannad, Thomas R. Fleming - Circulation 2004 被引用: 1,230

  2. Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    著者: Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, Theresa Gamble, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James Hakim, Johnstone Kumwenda, Beatriz Grinsztejn, José Henrique Pilotto, Sheela Godbole, Sanjay Mehendale, Suwat Chariyalertsak, Breno Santos, Kenneth H. Mayer, Irving Hoffman, Susan H. Eshleman, Estelle Piwowar‐Manning, Lei Wang, Joseph Makhema, Lisa Mills, Guy de Bruyn, Ian Sanne, Joseph J. Eron, Joel E. Gallant, Diane V. Havlir, Susan Swindells, Heather J. Ribaudo, Vanessa Elharrar, David Burns, Taha E. Taha, Karin Nielsen‐Saines, David D. Celentano, Max Essex, Thomas R. Fleming - New England Journal of Medicine 2011 被引用: 6,962

  3. Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    著者: Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, Theresa Gamble, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James Hakim, Johnstone Kumwenda, Beatriz Grinsztejn, José Henrique Pilotto, Sheela Godbole, Suwat Chariyalertsak, Breno Santos, Kenneth H. Mayer, Irving Hoffman, Susan H. Eshleman, Estelle Piwowar‐Manning, Leslie Cottle, Xinyi C. Zhang, Joseph Makhema, Lisa Mills, Ravindre Panchia, Sharlaa Faesen, Joseph J. Eron, Joel E. Gallant, Diane V. Havlir, Susan Swindells, Vanessa Elharrar, David Burns, Taha E. Taha, Karin Nielsen‐Saines, David D. Celentano, Max Essex, Sarah E. Hudelson, Andrew D. Redd, Thomas R. Fleming - New England Journal of Medicine 2016 被引用: 1,726

  4. A Multiple Testing Procedure for Clinical Trials

    著者: Peter C. O’Brien, Thomas R. Fleming - Biometrics 1979 被引用: 3,349

  5. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension

    著者: Nazzareno Galiè, Hossein Ardeschir Ghofrani, Adam Torbicki, Robyn J. Barst, Lewis J. Rubin, David B. Badesch, Thomas R. Fleming, Tamiza Parpia, Gary Burgess, Angelo Branzi, Friedrich Grimminger, Marcin Kurzyna, Gérald Simonneau - New England Journal of Medicine 2005 被引用: 2,470

  6. Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial

    著者: Jon T. Giles, Naveed Sattar, Sherine E. Gabriel, Paul M. Ridker, Steffen Gay, Charles Warne, David Musselman, Laura Brockwell, Emma Shittu, Micki Klearman, Thomas R. Fleming - Arthritis & Rheumatology 2019 被引用: 233

  7. Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial

    著者: Elia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, Tim A Benke, J Helen Cross, Scott T Demarest, Heather E Olson, Nicola Specchio, Thomas R Fleming, Alex A Aimetti, Maciej Gasior, Orrin Devinsky, Elena Belousova, Oleg Belyaev, Bruria Ben-Zeev, Andreas Brunklaus, Michael A. Ciliberto, Francesca Darra, Ronald Davis, Valentina De Giorgis, Olga Doronina, Michael Fahey, Renzo Guerrini, Peter Heydemann, Olga Khaletskaya, Pawel Lisewski, Eric D. Marsh, Ahsan N. Moosa, Scott Perry, Sunny Philip, Rajsekar R. Rajaraman, Ben Renfroe, Russell P. Saneto, Ingrid E. Scheffer, Yoshimi Sogawa, Bernhardt Suter, Matthew T. Sweney, Daniel Tarquinio, Pierangelo Veggiotti, Geoff Wallace, Judy Weisenberg, Angus Wilfong, Elaine C. Wirrell, Muhammad Zafar, Marta Zolnowska - The Lancet Neurology 2022 被引用: 152

  8. Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial

    著者: Elia Pestana‐Knight, Sam Amin, Nadia Bahi‐Buisson, Tim A. Benke, J. Helen Cross, Scott Demarest, Heather E. Olson, Nicola Specchio, Thomas R. Fleming, Alex A. Aimetti, Maciej Ga̧sior, Orrin Devinsky, Marigold Trial Group - 2022 被引用: 130

  9. Biomarkers and surrogate endpoints in clinical trials

    著者: Thomas R. Fleming, John H. Powers - Statistics in Medicine 2012 被引用: 530

  10. Surrogate End Points in Clinical Trials: Are We Being Misled?

    著者: Thomas R. Fleming, David L. DeMets - Annals of Internal Medicine 1996 被引用: 1,633

  11. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency

    著者: Ganesh Raghu, Marya Ghazipura, Thomas R. Fleming, Kerri I. Aronson, Jürgen Behr, Kevin M. Brown, Kevin R. Flaherty, Ella A. Kazerooni, Toby M. Maher, Luca Richeldi, Joseph A. Lasky, Jeffrey J. Swigris, Robert Busch, Lili Garrard, Dong-Hyun Ahn, Ji Li, Khalid Puthawala, Gabriela Rodal, Sally Seymour, Nargues Weir, Sonye K. Danoff, Neil Ettinger, Jonathan Goldin, Marilyn K. Glassberg, Letícia Kawano-Dourado, Nasreen Khalil, Lisa Lancaster, David A. Lynch, Yolanda Mageto, Imre Noth, Jessica Shore, Marlies Wijsenbeek, Robert S. Brown, Daniel Grogan, Dorothy Ivey, Patrycja Golińska, Banu A. Karimi-Shah, Fernando J. Martínez - American Journal of Respiratory and Critical Care Medicine 2024 被引用: 76

  12. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

    著者: Charles G. Moertel, Thomas R. Fleming, John S. Macdonald, Daniel G. Haller, John A. Laurie, Phyllis J. Goodman, James S. Ungerleider, William A. Emerson, Douglas C. Tormey, John H. Glick, Michael H. Veeder, James A. Mailliard - New England Journal of Medicine 1990 被引用: 2,258

  13. An introduction to the Marburg virus vaccine consortium, MARVAC

    著者: Robert W. Cross, Ira M. Longini, Stephan Becker, Karin Bok, David Boucher, Miles W. Carroll, Janet Dı́az, William E. Dowling, Ruxandra Draghia‐Akli, James T. Duworko, John M. Dye, Michael A. Egan, Patricia Fast, Amy Finan, Courtney L. Finch, Thomas R. Fleming, Joan Fusco, Thomas W. Geisbert, Anthony Griffiths, Stephan Günther, Lisa E. Hensley, Anna N. Honko, Ruth Hunegnaw, Jocelyn Jakubik, Julie E. Ledgerwood, Kerstin Lühn, Demetrius Matassov, Jeffrey Meshulam, Emily V. Nelson, Christopher L. Parks, Roxana Rustomjee, David Safronetz, Lauren M. Schwartz, Dean Smith, Paul Smock, Ydrissa Sow, Christina F. Spiropoulou, Nancy J. Sullivan, Kelly L. Warfield, Daniel Wolfe, Courtney Woolsey, Roland Zahn, Ana María Henao-Restrepo, César Muñoz‐Fontela, Andrea Marzi - PLoS Pathogens 2022 被引用: 54

  14. When to update COVID-19 vaccine composition

    著者: Rebecca Grant, Jilian A. Sacks, Priya Abraham, Supamit Chunsuttiwat, Cheryl Cohen, J. Peter Figueroa, Thomas R. Fleming, Paul V. A. Fine, David Goldblatt, Hideki Hasegawa, C. Raina MacIntrye, Ziad A. Memish, Elizabeth Miller, Sérgio de Andrade Nishioka, Amadou A. Sall, Samba O. Sow, Oyewale Tomori, Youchun Wang, Maria D. Van Kerkhove, Marie-Ange Wambo, Homa Attar Cohen, Samuel Mesfin, James R. Otieno, Lorenzo Subissi, Sylvie Briand, David E. Wentworth, Kanta Subbarao - Nature Medicine 2023 被引用: 51

  15. Counting Processes and Survival Analysis.

    著者: Dorota M. Dabrowska, Thomas R. Fleming, David P. Harrington - Journal of the American Statistical Association 1992 被引用: 2,315

  16. High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy

    著者: Charles G. Moertel, Thomas R. Fleming, Edward T. Creagan, Joseph Rubin, Michael J. O’Connell, Matthew M. Ames - New England Journal of Medicine 1985 被引用: 627

  17. ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER

    著者: D. Y. Lin, Thomas R. Fleming, Victor De Gruttola - Statistics in Medicine 1997 被引用: 511

  18. openalex_id:w3201408162

    著者: Philip R. Krause, Thomas R. Fleming, Richard Peto, Ira M. Longini, J. Peter Figueroa, Jonathan A C Sterne, Alejandro Cravioto, Helen Rees, Julian P. T. Higgins, Isabelle Boutron, Hongchao Pan, Marion F. Gruber, Narendra K. Arora, Fatema Kazi, Rogerio Gaspar, Soumya Swaminathan, Michael J. Ryan, Ana‐Maria Henao‐Restrepo 被引用: 372

  19. The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough

    著者: Surinder S. Birring, Thomas R. Fleming, Sérgio Matos, A A Raj, David H. Evans, Ian Pavord - European Respiratory Journal 2008 被引用: 303

  20. SARS-CoV-2 Variants and Vaccines

    著者: Philip R. Krause, Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba-Maria Ropero, Ran D. Balicer, Jakob P. Cramer, César Muñoz‐Fontela, Marion F. Gruber, Rogerio Gaspar, Jerome Amir Singh, Kanta Subbarao, Maria D. Van Kerkhove, Soumya Swaminathan, Michael J. Ryan, Ana‐Maria Henao‐Restrepo - New England Journal of Medicine 2021 被引用: 425

  21. FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit

    著者: Jason S. Kim, Silvana Borges, Daniel J. Clauw, Philip G. Conaghan, David T. Felson, Thomas R. Fleming, R. Gläser, Elizabeth Hart, Marc C. Hochberg, Yura Kim, Virginia B. Kraus, Larissa Lapteva, Xiaojuan Li, Sharmila Majumdar, Timothy E. McAlindon, Ali Mobasheri, Tuhina Neogi, Frank W. Roemer, Rebecca Rothwell, Robert Shibuya, Jeffrey Siegel, Lee S. Simon, Kurt P. Spindler, Nikolay P. Nikolov - Seminars in Arthritis and Rheumatism 2022 被引用: 29

  22. Prognosis in primary biliary cirrhosis: Model for decision making

    著者: Rolland E. Dickson, Patricia M. Grambsch, Thomas R. Fleming, Lloyd D. Fisher, Alice Langworthy - Hepatology 1989 被引用: 822

  23. A class of rank test procedures for censored survival data

    著者: David P. Harrington, Thomas R. Fleming - Biometrika 1982 被引用: 1,175

  24. Surrogate Endpoints And FDA’s Accelerated Approval Process

    著者: Thomas R. Fleming - Health Affairs 2005 被引用: 248